Home>Topics>Stocks>AstraZeneca PLC ADR

AstraZeneca PLC ADR AZN

  1. All
  2. Commentary
  3. Stock Reports
  4. Video Reports
  5. Fund Reports
  6. ETF Reports
  7. Headlines
    1. “Tax Reform is Impossible – Until it is Inevitable”

      Headlines

      Tue, 22 Jul 2014

      S. businesses to move operations (and jobs) overseas. This year Pfizer made a bid (since withdrawn) to take over AstraZeneca in part for the taxes Pfizer would save by moving its headquarters from the United States to London. Last year the CEO of

    2. Advaxis and MedImmune team up in cancer immunotherapy

      Headlines

      Tue, 22 Jul 2014

      Advaxis (NASDAQ: ADXS ) and AstraZeneca 's (NYSE: AZN ) MedImmune establish a clinical trial collaboration to evaluate the safety and efficacy of MedImmune's investigational anti

    3. AstraZeneca widens cancer immunotherapy net with Advaxis trial

      Headlines

      Tue, 22 Jul 2014

      LONDON, July 22 (Reuters) - AstraZeneca is casting its net wider in the hot cancer immunotherapy field through a clinical trial collaboration with U.S. biotech firm Advaxis that will test drugs from both companies in combination.

    4. 5 More Possible Partners For MannKind's Afrezza, Each With A Strong Diabetes Care Franchise

      Headlines

      Mon, 21 Jul 2014

      By Psycho Analyst : My previous article looked at the five largest global Big Pharma companies, ranked by revenues, to see if any of them might be the partner MannKind (NASDAQ: MNKD ) needs to market and distribute its just-approved, novel, ultra-fast acting, inhaled insulin, Afrezza. But there are

    5. Attractive tax inversion targets remain, analysts say

      Headlines

      Mon, 21 Jul 2014

      has been mentioned as a potential suitor for Smith& Nephew. Pfizer (NYSE: PFE ) may make another run at AstraZeneca (NYSE: AZN ) after the end of the cool-off period. Post your comment!

    6. Patient enrollment for Synergy OIC drug trial complete

      Headlines

      Thu, 17 Jul 2014

      bowel movements during Week 4 of the Treatment Period. Synergy intends to release top-line data from the trial in Q4. Related tickers: ( NKTR -5.2% ) ( AZN -2.1% ) ( CBST -0.8% ) ( SLXP -1.6% ) ( PGNX ) Post your comment!

    7. CORRECTED-UPDATE 1-Shire, AbbVie to announce $53 bln merger by Friday -sources

      Headlines

      Thu, 17 Jul 2014

      (Corrects paragraph 7 to show failed bid for AstraZeneca happened in May not June))

    8. CORRECTED-Shire, AbbVie to announce $53 billion merger by Friday -sources

      Headlines

      Thu, 17 Jul 2014

      (Corrects 6th paragraph to show Pfizer's failed bid for AstraZeneca happened in May not June)

    9. Xalkori: Pfizer's Lung Cancer Drug Might Get A Future Boost In Sales

      Headlines

      Thu, 17 Jul 2014

      that Pfizer (NYSE: PFE ) has had a rocky first half this year. The difficulties around its attempt to acquire AstraZeneca (NYSE: AZN ) were compounded by Q1 sales that missed market expectations by 9 percent. As it had announced last October

    10. Medtronic Not Sticking Around To Rearrange Chairs On The Titanic

      Headlines

      Mon, 14 Jul 2014

      Walgreen (NYSE: WAG ) and its plans to move to Switzerland , Pfizer's (NYSE: PFE ) failed bid for UK-based AstraZeneca (NYSE: AZN ), and now Medtronic's (NYSE: MDT ) acquisition of Ireland-based Covidien (NYSE: COV ), it's very

    « Prev12345Next »
    Content Partners